Opportunity Information: Apply for RFA RM 11 011
Apply for RFA RM 11 011
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Human Heredity and Health in Africa (H3Africa) H3Africa Biorepository Grants. (UH2/UH3)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172 Human Genome Research 93.310 Trans NIH Research Support.
- This funding opportunity was created on Oct 17, 2011 and posted on Sep 14, 2011.
- Applicants must submit their applications by Dec 19, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Organizations) African institutions are eligible for the awards Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Human Heredity and Health in Africa (H3Africa) H3Africa Biorepository Grants (UH2/UH3) funding opportunity, issued by the National Institutes of Health (NIH) under Funding Opportunity Number RFA-RM-11-011, was designed to help build a major shared research resource on the African continent: an H3Africa biorepository. The core purpose of the award was to support an international site in Africa that could reliably receive, process as needed, store, and distribute biological samples generated by H3Africa research projects, while also serving other African genomic research studies. In practical terms, the biorepository envisioned by this FOA would function as a centralized or coordinating hub that strengthens long-term research infrastructure, improves sample stewardship and quality systems, and enables broader scientific use of African biospecimens in a way that supports health research and disease-focused genomics.
This FOA was backed by the NIH Common Fund along with participating NIH Institutes and Centers, and it explicitly aligned with the broader H3Africa initiative, which is a partnership between NIH and the Wellcome Trust. The bigger picture goal of H3Africa is capacity-building: creating sustainable research capability in Africa by using genomics and related approaches to better understand disease and promote health. Within that framework, a well-run biorepository is not just a storage facility; it is an enabling platform for high-quality, ethically grounded, and logistically dependable biomedical research. By supporting the establishment or development of a biorepository, the NIH aimed to make it easier for African-led and Africa-focused genomics projects to manage specimens to international standards and to share them appropriately for future studies.
The funding mechanism was a cooperative agreement, meaning NIH expected substantial programmatic involvement alongside the awardee rather than a hands-off grant structure. The activity category was health, and the relevant CFDA listings were 93.172 (Human Genome Research) and 93.310 (Trans-NIH Research Support). There was no cost sharing or matching requirement stated for applicants, which lowers a common barrier for institutions building infrastructure-heavy resources like biobanks.
Eligibility was centered on non-U.S. entities, with African institutions specifically eligible and explicitly invited. Eligible applicants included foreign organizations located in African countries, non-domestic components of U.S. organizations, and foreign components as defined in the NIH Grants Policy Statement. The opportunity also listed public/state-controlled and private institutions of higher education among eligible applicant types, along with “others†as clarified in the NIH eligibility language. Overall, the eligibility framing reinforced the intention that the biorepository capacity being funded should be based in Africa and benefit African genomics research networks.
Key dates show this was a time-limited solicitation: it was posted September 14, 2011, created October 17, 2011, with an original closing date of December 2, 2011, later extended to December 19, 2011. The archive date was January 19, 2012, indicating the announcement is no longer active but remains part of the historical NIH funding record.
For applicants and institutions wanting to review the full requirements and detailed expectations, the FOA pointed to the NIH grants guide webpage (http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-11-011.html). Administrative help for access or linking issues was directed to the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is the Human Heredity and Health in Africa (H3Africa) Biorepository Grants (UH2/UH3) issued by the National Institutes of Health (NIH) under Funding Opportunity Number (FON) RFA-RM-11-011.
What is the main purpose of the H3Africa Biorepository award?
The core purpose was to build a major shared research resource on the African continent: an H3Africa biorepository. The award was intended to support an international site in Africa that could reliably receive, process as needed, store, and distribute biological samples generated by H3Africa research projects, while also serving other African genomic research studies.
What would the biorepository be expected to do in practical terms?
The biorepository envisioned by this FOA would function as a centralized or coordinating hub that strengthens long-term research infrastructure, improves sample stewardship and quality systems, and enables broader scientific use of African biospecimens in support of health research and disease-focused genomics.
Is the biorepository intended to serve only H3Africa projects?
No. While it was designed to handle biological samples generated by H3Africa research projects, it was also intended to serve other African genomic research studies.
How does this opportunity fit within the broader H3Africa initiative?
This FOA explicitly aligned with the broader H3Africa initiative, a partnership between NIH and the Wellcome Trust. The larger goal of H3Africa is capacity-building in Africa by using genomics and related approaches to better understand disease and promote health. Within that framework, the biorepository is an enabling platform for high-quality, ethically grounded, and logistically dependable biomedical research.
Who funded or supported this FOA within NIH?
This FOA was backed by the NIH Common Fund along with participating NIH Institutes and Centers.
What kind of grant mechanism was used?
The funding mechanism was a cooperative agreement. That means NIH expected substantial programmatic involvement alongside the awardee, rather than a fully hands-off grant structure.
What are the relevant CFDA numbers for this opportunity?
The relevant CFDA listings were 93.172 (Human Genome Research) and 93.310 (Trans-NIH Research Support).
What activity category does this opportunity fall under?
The activity category was health.
Was cost sharing or matching required?
No cost sharing or matching requirement was stated for applicants in the information provided.
Who was eligible to apply?
Eligibility was centered on non-U.S. entities, with African institutions specifically eligible and explicitly invited. Eligible applicants included foreign organizations located in African countries, non-domestic components of U.S. organizations, and foreign components as defined in the NIH Grants Policy Statement.
What types of institutions were included among eligible applicants?
The opportunity listed public/state-controlled and private institutions of higher education among eligible applicant types, along with "others" as clarified in NIH eligibility language.
Does the eligibility focus suggest where the biorepository should be based?
Yes. The eligibility framing reinforced the intention that the biorepository capacity being funded should be based in Africa and benefit African genomics research networks.
When was this FOA posted and created?
It was posted on September 14, 2011, and created on October 17, 2011.
What was the application closing date?
The original closing date was December 2, 2011, and it was later extended to December 19, 2011.
Is this funding opportunity still open?
No. The archive date was January 19, 2012, which indicates the announcement is no longer active and remains part of the historical NIH funding record.
Where can applicants find the full FOA details and requirements?
The FOA pointed to the NIH grants guide webpage: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-11-011.html
Who should be contacted for administrative help related to access or linking issues?
Administrative help for access or linking issues was directed to the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
What long-term outcomes was NIH trying to support through this biorepository?
Based on the description provided, NIH aimed to strengthen long-term research infrastructure in Africa, improve specimen stewardship and quality systems, and enable broader scientific use of African biospecimens to support health research and disease-focused genomics.
Browse more opportunities from the same category: Health
Next opportunity: Manage/provide water access to and provide public information about Boston Harbor Islands including a science symposium
Previous opportunity: Scholarly Editions and Translations
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA RM 11 011
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA RM 11 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Viral Hepatitis Surveillance Apply for CDC RFA PS12 1203 Funding Number: CDC RFA PS12 1203 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| NIDCR Clinical Trial or Biomarker Clinical Evaluation Study Planning Grant (R34) Apply for PAR 11 338 Funding Number: PAR 11 338 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Clinical Trial Implementation or Biomarker Clinical Evaluation Study Cooperative Agreement (U01) Apply for PAR 11 339 Funding Number: PAR 11 339 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms Explaining Differences in Depressive and Anxiety Disorders Across Racial/Ethnic Groups (R01) Apply for RFA MH 12 090 Funding Number: RFA MH 12 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AIDS Education and Training Centers (AETC) National Evaluation Center (NEC) Apply for HRSA 12 071 Funding Number: HRSA 12 071 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Neurological Emergencies Treatment Trials (NETT) Network Clinical Site Hubs for year 2011 (U10) Apply for PAR 11 342 Funding Number: PAR 11 342 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIH Directors Transformative Research Awards (R01) Apply for RFA RM 11 006 Funding Number: RFA RM 11 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Clinical Trials (U01) Apply for PAR 11 343 Funding Number: PAR 11 343 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Small Business Innovation in Clinical Trials (U44) Apply for PAR 11 345 Funding Number: PAR 11 345 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Infrastructure Resource Access (X01) Apply for PAR 11 344 Funding Number: PAR 11 344 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rural Health Care Services Outreach Grant Program Apply for HRSA 12 083 Funding Number: HRSA 12 083 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NINDS SBIR Technology Transfer (SBIR TT R43/R44) Apply for PA 11 347 Funding Number: PA 11 347 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIDCR Limited Competition Renewals of Existing Cooperative Agreement Awards, Prospective Studies on Craniofacial Pain and Dysfunction RFA DE 05 007 (U01) Apply for PAR 11 348 Funding Number: PAR 11 348 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Hubs for International Research on Mental Health (U19) Apply for RFA MH 12 110 Funding Number: RFA MH 12 110 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Tuskegee University Apology Commemoration Activities Apply for CDC RFA PS12 1202 Funding Number: CDC RFA PS12 1202 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $180,000 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Wisconsin) Apply for PA FPH 12 012 Funding Number: PA FPH 12 012 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $3,671,742 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (West Virginia) Apply for PA FPH 12 013 Funding Number: PA FPH 12 013 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $2,405,407 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Pennsylvania, Western, Northeastern, and Central) Apply for PA FPH 12 014 Funding Number: PA FPH 12 014 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $3,941,586 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Georgia) Apply for PA FPH 12 015 Funding Number: PA FPH 12 015 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $8,229,100 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Kentucky) Apply for PA FPH 12 016 Funding Number: PA FPH 12 016 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $5,621,689 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 11 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
